Aspen Aerogels, Inc. (NYSE:ASPN) Given Average Recommendation of “Hold” by Analysts

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have been given an average rating of “Hold” by the six research firms that are presently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation, one has issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $6.6667.

A number of analysts have recently issued reports on ASPN shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Monday, December 29th. Canaccord Genuity Group dropped their target price on shares of Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating for the company in a report on Friday, November 7th. Barclays cut their price target on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating for the company in a research note on Friday, November 7th. Finally, Zacks Research upgraded Aspen Aerogels from a “strong sell” rating to a “hold” rating in a research report on Thursday, January 15th.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Raymond James Financial Inc. boosted its stake in Aspen Aerogels by 6.8% in the 2nd quarter. Raymond James Financial Inc. now owns 26,559 shares of the construction company’s stock worth $157,000 after purchasing an additional 1,687 shares during the period. Legal & General Group Plc lifted its holdings in shares of Aspen Aerogels by 3.6% in the second quarter. Legal & General Group Plc now owns 67,130 shares of the construction company’s stock worth $397,000 after buying an additional 2,324 shares in the last quarter. Osaic Holdings Inc. boosted its position in shares of Aspen Aerogels by 29.1% during the second quarter. Osaic Holdings Inc. now owns 10,615 shares of the construction company’s stock worth $63,000 after acquiring an additional 2,390 shares during the last quarter. SBI Securities Co. Ltd. grew its stake in Aspen Aerogels by 67.3% during the second quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock valued at $38,000 after acquiring an additional 2,551 shares in the last quarter. Finally, The Manufacturers Life Insurance Company increased its holdings in Aspen Aerogels by 12.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 24,671 shares of the construction company’s stock valued at $146,000 after acquiring an additional 2,656 shares during the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Aspen Aerogels Trading Down 2.1%

Aspen Aerogels stock opened at $3.54 on Tuesday. Aspen Aerogels has a 12-month low of $2.80 and a 12-month high of $9.78. The firm has a market capitalization of $292.17 million, a price-to-earnings ratio of -0.95 and a beta of 2.99. The firm has a 50 day moving average of $3.31 and a 200 day moving average of $5.13. The company has a current ratio of 3.94, a quick ratio of 3.33 and a debt-to-equity ratio of 0.28.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.